It has been proposed that long-lived memory T cells generated by vaccination or infection reside within a memory compartment that has a finite size. Consequently, in a variety of acute infection models interclonal competition has been shown to lead to attrition of preexisting memory CD8 ؉ T cells. Contrary to expectations, therefore, we found that chronic Leishmania donovani infection of Listeria-immune mice results in heightened protection against subsequent Listeria challenge. This protection was associated with bystander expansion of Listeria-specific CD8 ؉ T cells and a bias in these cells toward a central memory T-cell phenotype with an enhanced capacity for gamma interferon production. We propose that splenomegaly, which is characteristic of visceral leishmaniasis and other tropical infections, may help promote heterologous immunity by resetting the size of the memory compartment during chronic infection.
Memory CD8 ϩ -T-cell responses play an essential role in mediating natural and vaccine-induced immunity to a range of important human pathogens, and the dynamics of the CD8 ϩ -T-cell response to a number of prototypic microbial infections has been extensively studied. Activation of naïve CD8 ϩ T cells results in rapid and extensive clonal expansion, followed by a clonal contraction phase. Subsequently, memory CD8 ϩ T cells persist at a higher frequency than their naïve precursors (at approximately 5% of the maximal clone size) and occupy space in a finite memory compartment (1, 7) . The mechanisms regulating memory cell persistence in this memory compartment are varied. For example, whereas cross-reactivity can promote the survival of preexisting memory CD8 ϩ T cells (18) (19) (20) 22) , clonal competition in the absence of cross-reactivity can promote attrition of preexisting memory CD8 ϩ T cells (4, 19) . In addition, inflammatory cytokines are also thought to play an important role in regulating memory CD8 ϩ -T-cell persistence (21) . In the latter case, recent mathematical modeling suggests that clonal contraction should occur rapidly to maintain homeostasis (1) .
In contrast to these studies with acute infection models, memory cell behavior during chronic infection is less well understood. A recent study demonstrated that in contrast to mice with acute lymphocytic choriomeningitis virus infection, mice with a chronic infection do not develop memory CD8 ϩ T cells with the capacity for long-term antigen-independent persis-tence. Memory CD8 ϩ cells in these mice exhibit reduced expression of interleukin-7 (IL-7) and IL-15 receptors and fail to undergo homeostatic proliferation (24) . However, the impact of chronic infection on the persistence of preexisting hostprotective memory CD8 ϩ T cells has not been described previously. Here, we demonstrate that Leishmania donovani infection of Listeria-immune mice results in significantly enhanced protection against lethal challenge and long-term bystander expansion of Listeria-specific memory CD8 ϩ T cells. We propose that infection-associated splenomegaly may reset the size of the memory compartment to avoid interclonal competition and allow the maintenance of preexisting immunity.
MATERIALS AND METHODS
Mice and pathogens. BALB/c mice were obtained from Charles River U.K. (Margate, United Kingdom) and were maintained under barrier conditions at the Biological Services Unit, London School of Hygiene and Tropical Medicine. Female mice that were 8 to 12 weeks old were used in all experiments. L. donovani amastigotes (LV9) were obtained from the spleens of infected Syrian hamsters and were isolated as described elsewhere (6) . Mice were infected intravenously via the lateral tail vein with 2 ϫ 10 7 amastigotes. Listeria monocytogenes was grown overnight in static culture at 37°C in tryptone soya agar (TSA) broth (Oxoid, United Kingdom). Bacteria were then washed twice in phosphatebuffered saline before resuspension in 30% glycerol-phosphate-buffered saline for storage at Ϫ70°C. For vaccination and challenge, bacterial stocks were freshly thawed and serially diluted in sterile saline. The injected dose was confirmed by plating on TSA plates. All animal procedures were approved by the London School of Hygiene and Tropical Medicine Animal Procedures Ethical Committee and were subject to United Kingdom Home Office Regulations.
Vaccination and challenge. Mice were inoculated with a vaccinating nonlethal dose containing ϳ5 ϫ 10 4 CFU Listeria, after which bacilli were cleared within 2 weeks (9; data not shown). At week 6 after vaccination, groups of mice (n ϭ 12) were infected with L. donovani or retained as controls. Approximately 10 weeks later, groups of mice were killed to assess the fate of Listeria-specific CD8 ϩ T cells or were challenged with 6 ϫ10 5 to 8 ϫ10 5 CFU Listeria, and the levels of protection were determined on day 3 after challenge. Naïve mice infected with this dose did not survive beyond day 3 (data not shown). Livers and spleens were removed and homogenized in fixed volumes of sterile saline and RPMI, respectively, and serial dilutions were plated in triplicate on TSA plates. After incubation for 24 h at 37°C, the number of colonies was determined, and total number of organ CFU was calculated.
In vitro restimulation of Listeria-immune CD8 ؉ T cells. Dendritic cells (DC)
were obtained by culturing BALB/c or C57BL/6 bone marrow cells in granulocyte-macrophage colony-stimulating factor for 7 days by using conventional protocols. Dendritic cells were plated in six-well plates and were infected at a multiplicity of infection of 10:1 with either Listeria or amastigotes of L. donovani OVA, a transgenic line of L. donovani expressing chicken ovalbumin (OVA) (15a) . When appropriate, control cultures received 5 g/ml LLO 91-99 or OVA 257-264 . Listeria infection was terminated using 50 g/ml gentamicin. After 4 h, DC were irradiated (3,000 R) and then plated overnight. CD8 ϩ T cells were isolated from spleens of Listeria-immune mice by using magnetic sorting and were added to DC at a 10:1 ratio. In control experiments, OVA-specific OT-1 T cells were used. Proliferative responses were assessed at day 3 using thymidine incorporation, and gamma interferon (IFN-␥) production by bulk CD8 ϩ T cells and by tetramer-positive CD8 ϩ T cells was determined on day 3 following incubation for 5 h in the presence of brefeldin A as described below.
Flow cytometry. CD8 ϩ cells were positively selected from spleen cell suspensions by magnetic sorting using anti-CD8␣ (Ly-2) MicroBeads (Miltenyi Biotec). Four-color flow cytometry was performed with spleen cell populations using fluorescein isothiocyanate-conjugated CD8 (Caltag, Burlingame, CA), phycoerythrin-conjugated anti-CD62L (MEL-14), biotinylated anti-CD44 (Pgp-1; detected with streptavidin-PerCP), allophycocyanin (APC)-conjugated anti-IFN-␥ (XMG1.2), or APC-conjugated rat immunoglobulin G1 as an isotype control (all obtained from BD Pharmingen, Oxon, United Kingdom). H2K d /LLO 91-99 tetramers were obtained from Proimmune (Oxford, United Kingdom) and used to detect LLO 91-99 -specific CD8 ϩ T cells. For intracellular detection of IFN-␥, spleen cells (1 ϫ 10 7 cells/ml) were restimulated in the presence or absence of 5 g/ml of LLO 91-99 (Proimmune) for 1 h, followed by 4 h in the presence of 10 g/ml brefeldin A (Sigma). Data were collected for Ͼ50,000 events using a FACSCalibur and were analyzed using the Cell Quest II software (BD). All mice (four to six mice per group per experiment) were analyzed individually.
Statistical analysis. Statistical analysis was performed using Student's t test, and a P value of Ͻ0.05 was considered significant. Each experiment was repeated independently at least twice, with similar results.
RESULTS AND DISCUSSION
To determine how L. donovani infection affected established CD8 ϩ -T-cell-dependent protective immunity to a heterologous pathogen, we first vaccinated mice with a sublethal dose of L. monocytogenes, prior to L. donovani infection. When chronic L. donovani infection was well established, mice were challenged with an otherwise lethal dose of Listeria. Control vaccinated mice were significantly, although moderately, protected in terms of tissue CFU (Fig. 1A ). Similar levels of protection were also observed in control unvaccinated mice infected with L. donovani ( Fig. 1A and B ), most likely as a result of enhanced local macrophage effector function (14) or bystander cytokine-dependent activation of irrelevant memory CD8 ϩ T cells (2, 12) . In contrast, Listeria-immune mice infected with L. donovani showed remarkably high levels of protection. In the spleen, the number of CFU was reduced to undetectable levels ( Fig. 1A) , whereas in the liver, the protection was ϳ1.5 log greater than that seen either in L. donovaniinfected, Listeria-naïve mice or in control vaccinated mice (Fig.  1B) . These data demonstrate that L. donovani infection both enhanced innate immunity to Listeria challenge and also significantly augmented vaccine-induced protection.
During chronic L. donovani infection, mice exhibited marked splenomegaly ( Fig. 2A ) that was accompanied by an increase in the number of total spleen memory CD44 hi CD8 ϩ T cells (2.6 ϫ 10 5 Ϯ 0.3 ϫ 10 5 and 21 ϫ 10 5 Ϯ 8 ϫ 10 5 cells in naïve and chronically infected mice, respectively; P Ͻ 0.005).
To determine whether this expansion of memory CD8 ϩ T cells had an effect on preestablished CD8 ϩ Listeria-specific memory CD8 ϩ T cells, we determined the numbers of H2K d /LLO 91-99 tetramer-positive cells (3). Listeria-immune mice had signifi-cantly greater numbers of tetramer-positive cells than Listerianaïve mice (Fig. 2B ). More importantly, almost fivefold more tetramer-positive cells could be recovered from L. donovaniinfected, Listeria-immune mice than from mice that were not infected with L. donovani (Fig. 2B) . Thus, L. donovani infection, rather than causing attrition of preexisting CD8 ϩ memory T cells, appeared to favor bystander expansion. To rule out the possibility that tetramer-positive cells in L. donovani-infected mice merely had a greater potential for proliferation than the cells in noninfected mice, we also determined the number of Together, these experiments demonstrated for the first time that L. donovani infection expands a population of memory CD8 ϩ T cells specific for a heterologous pathogen. Although the number of tetramer-positive cells was not increased by L. donovani infection of naïve mice, it was still possible that LLO 91-99 -specific memory CD8 ϩ T cells might show some cross-reactivity with L. donovani that was more readily expressed due to the lower threshold for activation of memory cells than for activation of naïve T cells. To address this possibility, we assessed the capacity of CD8 ϩ T cells from Listeria-immune mice to recognize either Listeria-or L. donovani-infected dendritic cells in vitro. Whereas bulk populations of CD8 ϩ T cells proliferated ( Fig. 3A) and secreted IFN-␥ ( Fig. 3B ) in response to Listeria-infected dendritic cells and to LLO 91-99 -pulsed dendritic cells, no such response was evident with dendritic cells infected with a transgenic line of L. donovani expressing OVA. Furthermore, tetramer-positive cells also failed to respond to these L. donovani-infected dendritic cells (Fig. 3C) . The lack of response in these cultures was not due to a failure in class I presentation, as DC infected with these transgenic L. donovani cells were capable of stimulating responses in OVA-specific class I-restricted OT-1 cells (data not shown). Based on these findings together with the in vivo data described above, we concluded that there is not significant recognition of L. donovani either by bulk Listeria-specific CD8 ϩ T cells or by the LLO 91-99 -specific tetramer-positive cells that expand during chronic L. donovani infection of Listeria-immune mice.
Recently, memory T cells have been subdivided on the basis on September 22, 2017 by guest http://iai.asm.org/ of CD44 and CD62L expression into two subsets. CD44 hi CD62L lo T effector memory (T EM ) cells represent cells that traffic to inflammatory sites and act as rapid effectors after reexposure to antigen (15, 23) . In contrast, CD44 hi CD62L hi T central memory (T CM ) cells have the capacity to migrate into peripheral lymphoid tissues (16) . The responsiveness of these two subsets of memory cells to cytokine-driven bystander proliferation has been partially characterized in vitro (8, 25) . However, the impact of chronic infection on the relative frequencies of heterologous antigen-specific T EM and T CM cells populations in vivo has not been documented previously. Examination of tetramer-positive cells in Listeria-immune mice indicated that approximately 60% were T CM cells, as defined by CD44 and CD62L staining. However, in Listeria-immune mice infected with L. donovani, the frequency of T CM cells was almost 80%, and reciprocal changes were observed in the T EM -cell population (Fig. 4A and B) . In absolute terms, the number of tetramer-positive T CM cells was approximately sevenfold greater in L. donovani-infected, Listeria-immune mice than in control Listeria-immune mice (102 ϫ10 3 Ϯ 27 ϫ 10 3 and 14.9 ϫ10 3 Ϯ 6.4 ϫ10 3 cells, respectively; P Ͻ 0.05; n ϭ 5 or 6). Thus, L. donovani infection significantly skewed the LLO 91-99specific memory CD8 ϩ -T-cell pool toward a T CM phenotype. A number of possibilities could explain this finding: the greater potential for homeostatic proliferation of T CM cells than of T EM cells (25) may be maintained in response to cytokines present in the inflammatory environment caused by L. donovani infection (6); the rate of conversion from T EM cells to T CM cells (25) might be enhanced in the environment of the L. donovani-infected spleen, by factors independent of the turnover rate; or tetramer-positive T EM cells may have been preferentially recruited from the spleen to other sites of L. dono- on September 22, 2017 by guest http://iai.asm.org/ vani infection (e.g., the liver). Further studies are required to differentiate between these possibilities. To assess the functional capacity of tetramer-positive cells expanded as a consequence of L. donovani infection, we restimulated spleen cells with 5 g/ml LLO 91-99 and then determined the frequency of IFN-␥-producing cells by flow cytometry. In nonimmune mice, very few LLO 91-99 -specific CD8 ϩ T cells were detectable after Listeria challenge, whether the mice had been infected with L. donovani or not ( Fig. 5A and B) . However, in Listeria-immune mice, LLO 91-99 -specific CD8 ϩ T cells were readily stimulated in vitro to produce IFN-␥. For spleen cells from L. donovani-infected, Listeria-immune mice, but not for spleen cells from L. donovani-infected, Listerianaïve mice, there was a marked increase in the frequency of LLO 91-99 -specific CD8 ϩ T cells able to make IFN-␥ (Fig. 5A) . The impact of L. donovani infection on the total capacity of the mice to make IFN-␥ in response to LLO 91-99 was even more evident after we adjusted for the total number of CD8 ϩ T cells in the spleen (Fig. 5B ). The levels of IFN-␥ produced by CD8 ϩ T cells in response to restimulation with LLO 91-99 were also different in these groups of mice. CD8 ϩ T cells from control Listeria-immune mice produced significantly more IFN-␥ when they were directly restimulated in vitro than CD8 ϩ T cells produced when they were restimulated 3 days after challenge infection ( Fig. 5C and D) . These data may reflect down-regulation of the T-cell receptor and associated molecules on the recently antigen-reactivated memory cells (10) . More strikingly, in mice infected with L. donovani, LLO 91-99 -specific CD8 ϩ T cells produced higher levels of IFN-␥ than the cells in control Listeria-immune mice produced ( Fig. 5C and D) . Hence, not only does L. donovani infection increase the numbers of LLO 91-99 -specific CD8 ϩ T cells in the spleens of Listeria-immune mice, but these cells have a heightened capacity to produce IFN-␥ when they are reexposed to antigen.
Concluding remarks. Our results identified a number of features associated with in vivo bystander CD8 ϩ -T-cell expansion that have not been reported previously. First, we found that infection with L. donovani augments vaccine-induced immunity to Listeria, expanding and enhancing the effector function of a host-protective LLO 91-99 -specific memory CD8 ϩ -Tcell population. The in vivo regulation of bystander expansion is likely to be both complex and highly dynamic and controlled by cytokines and costimulatory receptor-ligand interactions (4, 5, 11, 13, 26) , and many of these parameters remain to be fully evaluated in our model. However, it is known that there is increased accumulation of IL-2 mRNA in mice with chronic L. donovani infections (6), and more recent preliminary studies indicate that IL-7 mRNA accumulation was not altered, while IL-15 mRNA accumulation was reduced in the spleens of infected mice compared to the spleens of naïve mice (Polley, unpublished data) . Second, our data indicate that as a consequence of L. donovani infection, LLO 91-99 -specific memory CD8 ϩ T cells acquire an enhanced functional capacity, as measured at the single-cell level by intracellular IFN-␥ production. The basis for this enhanced responsiveness remains to be determined, but the responsiveness is consistent with previous findings which showed that there was bystander enhancement of IFN-␥ production (12) . Finally, the increase in heterologous memory CD8 ϩ T cells that accompanies L. donovani infection was contrary to our expectations based on the concept of a finite size for the memory pool (7) and evidence from viral infection models indicating that non-cross-reactive infections can cause attrition of preexisting memory (17, 18) . In this respect, it is tempting to speculate that the splenomegaly associated with L. donovani infection, and indeed with other chronic parasitic infections, such as malaria and schistosomiasis, may override some of the constraints normally imposed on the memory compartment under steady-state conditions, resetting a new level of homeostasis in the enlarged spleen. Given the global burden of these infections, the extent to which chronic or recurrent splenomegaly and/or lymphadenopathy may affect the memory CD8 ϩ -T-cell compartment clearly warrants further experimental and clinical study.
